NanoVibronix, Inc. financial data

Symbol
NAOV on Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
969 Pruitt Ave,, Tyler, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
Nano Vibronix, Inc. (to 3/25/2014), Nano Vibronix Inc (to 5/5/2005)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 223 % -0.38%
Quick Ratio 100 % -11.9%
Debt-to-equity 90.8 % -3.2%
Return On Assets -53 % +41.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.75M shares +83.4%
Common Stock, Shares, Outstanding 2.78M shares +51.1%
Entity Public Float 4.83M USD -72.5%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 2.8M shares +62.9%
Weighted Average Number of Shares Outstanding, Diluted 2.8M shares +62.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.29M USD +228%
Cost of Revenue 1.33M USD +164%
Research and Development Expense 619K USD +169%
Selling and Marketing Expense 778K USD -6.94%
General and Administrative Expense 3.48M USD -10.2%
Operating Income (Loss) -2.91M USD +34.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.06M USD +38%
Income Tax Expense (Benefit) 25K USD +66.7%
Net Income (Loss) Attributable to Parent -3.09M USD +37.7%
Earnings Per Share, Basic -1.22 USD/shares +61.4%
Earnings Per Share, Diluted -1.22 USD/shares +14.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.97M USD -77.1%
Accounts Receivable, after Allowance for Credit Loss, Current 580K USD +1713%
Inventory, Net 2.25M USD -29.2%
Assets, Current 4.38M USD -38.9%
Property, Plant and Equipment, Net 9K USD +28.6%
Operating Lease, Right-of-Use Asset 126K USD +563%
Other Assets, Noncurrent 1K USD -66.7%
Assets 4.68M USD -36.4%
Accounts Payable, Current 25K USD -59.7%
Liabilities, Current 2.52M USD +5.39%
Operating Lease, Liability, Noncurrent 77K USD
Liabilities 2.81M USD +5.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -75K USD -38.9%
Retained Earnings (Accumulated Deficit) -68.4M USD -4.73%
Stockholders' Equity Attributable to Parent 1.87M USD -60.1%
Liabilities and Equity 4.68M USD -36.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -579K USD +51.8%
Net Cash Provided by (Used in) Financing Activities 7K USD
Net Cash Provided by (Used in) Investing Activities -1K USD 0%
Common Stock, Shares Authorized 40M shares 0%
Common Stock, Shares, Issued 2.78M shares +51.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -583K USD +51.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.31M USD -65.5%
Operating Lease, Liability 126K USD +563%
Payments to Acquire Property, Plant, and Equipment 1K USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.11M USD +38%
Lessee, Operating Lease, Liability, to be Paid 142K USD +610%
Operating Lease, Liability, Current 49K USD +158%
Lessee, Operating Lease, Liability, to be Paid, Year Two 58K USD +1833%
Lessee, Operating Lease, Liability, to be Paid, Year One 60K USD +253%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 16K USD +1500%
Additional Paid in Capital 70.3M USD +0.41%
Depreciation, Depletion and Amortization 1K USD
Share-based Payment Arrangement, Expense 36K USD -69%
Interest Expense 134K USD -5.71%